Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank100
3Y CAGR+6.1%
5Y CAGR+8.3%
Year-over-Year Change
Diluted earnings per share
3Y CAGR
+6.1%/yr
vs +12.2%/yr prior
5Y CAGR
+8.3%/yr
Consistent
Acceleration
-6.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 15.32 | +836.5% |
| 2024 | -2.08 | -115.0% |
| 2023 | 13.89 | +8.3% |
| 2022 | 12.82 | +42.3% |
| 2021 | 9.01 | -12.4% |
| 2020 | 10.29 | +128.2% |
| 2019 | 4.51 | -44.3% |
| 2018 | 8.09 | +677.9% |
| 2017 | 1.04 | +326.1% |
| 2016 | -0.46 | - |